DK481388A - Calciumtilskud - Google Patents

Calciumtilskud

Info

Publication number
DK481388A
DK481388A DK481388A DK481388A DK481388A DK 481388 A DK481388 A DK 481388A DK 481388 A DK481388 A DK 481388A DK 481388 A DK481388 A DK 481388A DK 481388 A DK481388 A DK 481388A
Authority
DK
Denmark
Prior art keywords
calcium
grants
malate
citrate
excipients
Prior art date
Application number
DK481388A
Other languages
English (en)
Other versions
DK481388D0 (da
Inventor
Stephen Allen Jacobs
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of DK481388D0 publication Critical patent/DK481388D0/da
Publication of DK481388A publication Critical patent/DK481388A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK481388A 1987-08-28 1988-08-29 Calciumtilskud DK481388A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9081387A 1987-08-28 1987-08-28

Publications (2)

Publication Number Publication Date
DK481388D0 DK481388D0 (da) 1988-08-29
DK481388A true DK481388A (da) 1989-03-02

Family

ID=22224448

Family Applications (1)

Application Number Title Priority Date Filing Date
DK481388A DK481388A (da) 1987-08-28 1988-08-29 Calciumtilskud

Country Status (13)

Country Link
EP (1) EP0304987B1 (da)
JP (1) JP2795651B2 (da)
KR (1) KR970009583B1 (da)
AT (1) ATE82120T1 (da)
AU (1) AU625809B2 (da)
CA (1) CA1314233C (da)
DE (1) DE3875867T2 (da)
DK (1) DK481388A (da)
HK (1) HK182096A (da)
IE (1) IE61452B1 (da)
IL (1) IL87452A (da)
NZ (1) NZ225950A (da)
ZA (1) ZA886355B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533724B1 (en) * 1990-06-14 1995-04-26 The Procter & Gamble Company Calcium citrate malate composition
ATE253921T1 (de) * 1991-05-06 2003-11-15 Procter & Gamble Kombinationen aus calzium und vitamin d
US5389387A (en) * 1991-12-26 1995-02-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
AU3240193A (en) * 1991-12-26 1993-07-28 Procter & Gamble Company, The Storage stable calcium-supplemented beverage concentrates
EP0665720B1 (en) * 1992-10-21 1996-07-10 The Procter & Gamble Company Storage stable calcium-supplemented beverage premix concentrates and syrups
EP0665719B1 (en) * 1992-10-21 1997-01-15 The Procter & Gamble Company Sweetener containing a concentrated bioavailable calcium source
ATE198122T1 (de) * 1992-10-21 2001-01-15 Procter & Gamble Konzentrierte, bioverfügbare kalziumquelle
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
JPH09173020A (ja) * 1995-12-28 1997-07-08 Shiro Tanaka クエン酸・リンゴ酸カルシウムの可溶性濃厚カルシウム凍結品／冷蔵品およびその製造法
WO2008020420A2 (en) * 2006-08-17 2008-02-21 The Procter & Gamble Company Compositions comprising calcium citrate malate and methods for making the same
CA2661062C (en) * 2006-08-17 2012-08-14 The Procter & Gamble Company Compositions comprising calcium citrate malate and methods for making the same
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
EP2790710B1 (en) 2011-12-13 2020-08-26 Amorphical Ltd. Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders
WO2016193983A1 (en) 2015-06-04 2016-12-08 Amorphical Ltd. Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration
JP7152785B2 (ja) 2016-10-25 2022-10-13 アモーフィカル リミテッド． 白血病治療のための非晶質炭酸カルシウム
CN112137787B (zh) * 2020-09-16 2023-01-06 张宏伟 一种足踝外科下胫腓关节复位固定导向器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697248A (en) * 1979-12-28 1981-08-05 Tanaka Shiro Conjugated compound of calcium citrate and calcium malate and its preparation
FR2601249A1 (fr) * 1986-07-09 1988-01-15 Sandoz Lab Nouvelles compositions pharmaceutiques a base de sels de calcium.
CA1319612C (en) * 1987-07-02 1993-06-29 Haile Mehansho Iron-calcium mineral supplements with enhanced bioavailability
US4786510A (en) * 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements

Also Published As

Publication number Publication date
DE3875867D1 (de) 1992-12-17
ATE82120T1 (de) 1992-11-15
KR890003391A (ko) 1989-04-14
ZA886355B (en) 1989-05-30
EP0304987A3 (en) 1990-02-21
HK182096A (en) 1996-10-11
IE61452B1 (en) 1994-11-02
JPH01156985A (ja) 1989-06-20
DK481388D0 (da) 1988-08-29
AU625809B2 (en) 1992-07-16
KR970009583B1 (en) 1997-06-14
CA1314233C (en) 1993-03-09
NZ225950A (en) 1991-10-25
AU2159888A (en) 1989-06-15
EP0304987A2 (en) 1989-03-01
IE882610L (en) 1989-02-28
IL87452A (en) 1992-07-15
DE3875867T2 (de) 1993-04-01
EP0304987B1 (en) 1992-11-11
IL87452A0 (en) 1989-01-31
JP2795651B2 (ja) 1998-09-10

Similar Documents

Publication Publication Date Title
DK481388D0 (da) Calciumtilskud
IL84425A (en) (s) - (+) -ibuprofen-containing pharmaceutical compositions
KR950009098B1 (en) Pharmaceutical composition for use in treating clot formation
GB2259647B (en) Medicaments for treating gastrointestinal disorders
SE9002500D0 (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
DK0389035T3 (da) Farmaceutisk præparat der indeholder en farmaceutisk egnet bærer og forbindelsen med strukturen (7alfa,17alfa)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
PT86205A (en) Process for the preparation of 3-]omega-(3,5-di-t-butil-4-hydroxyphenyl)-alkanoyl"pyrroles and their de-oxy analogs useful in therapy
IT1215332B (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
ATE59550T1 (de) Chlorpheniramine therapie.
IT1224250B (it) Associzione del depiprazolo con la morfina
DE3786168D1 (de) Verwendung von para-aminobenzoesaeure zur herstellung eines arzneimittels zur bekaempfung von photoallergien.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment